These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27550043)

  • 21. Exencephaly and axial skeletal malformations induced by maternal administration of sodium valproate in the MF1 mouse.
    Padmanabhan R; Hameed MS
    J Craniofac Genet Dev Biol; 1994; 14(3):192-205. PubMed ID: 7852547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping a chromosomal locus for valproic acid-induced exencephaly in mice.
    Lundberg YW; Cabrera RM; Greer KA; Zhao J; Garg R; Finnell RH
    Mamm Genome; 2004 May; 15(5):361-9. PubMed ID: 15170225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of supplemental folic acid on valproic acid-induced embryotoxicity and tissue zinc levels in vivo.
    Hansen DK; Grafton TF; Dial SL; Gehring TA; Siitonen PH
    Teratology; 1995 Nov; 52(5):277-85. PubMed ID: 8838251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
    Ornoy A
    Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of concordance between heat shock proteins and the development of tolerance to teratogen-induced neural tube defects.
    Finnell RH; Van Waes M; Bennett GD; Eberwine JH
    Dev Genet; 1993; 14(2):137-47. PubMed ID: 8482018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydroxamic acid and fluorinated derivatives of valproic acid: anticonvulsant activity, neurotoxicity and teratogenicity.
    Gravemann U; Volland J; Nau H
    Neurotoxicol Teratol; 2008; 30(5):390-4. PubMed ID: 18455366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Cbp, p300 and Akt in valproic acid induced neural tube defects in CD-1 mouse embryos.
    Shafique S; Winn LM
    Reprod Toxicol; 2020 Aug; 95():86-94. PubMed ID: 32445665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of embryotoxicity using mouse embryo culture.
    Winn LM; Tung EW
    Methods Mol Biol; 2009; 550():241-9. PubMed ID: 19495708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transfer of valproic acid and its main active unsaturated metabolite to the gestational tissue: correlation with neural tube defect formation in the mouse.
    Nau H
    Teratology; 1986 Feb; 33(1):21-7. PubMed ID: 3090732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pantothenic acid decreases valproic acid-induced neural tube defects in mice (I).
    Sato M; Shirota M; Nagao T
    Teratology; 1995 Sep; 52(3):143-8. PubMed ID: 8638254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valproic acid prenatal exposure. Association with lipomyelomeningocele.
    Carter BS; Stewart JM
    Clin Pediatr (Phila); 1989 Feb; 28(2):81-5. PubMed ID: 2492459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Action of valproic acid on Xenopus laevis development: teratogenic effects on eyes.
    Pennati R; Groppelli S; de Bernardi F; Sotgia C
    Teratog Carcinog Mutagen; 2001; 21(2):121-33. PubMed ID: 11223890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myo-inositol enhances teratogenicity of valproic acid in the mouse.
    Massa V; Wlodarczyk B; Giavini E; Finnell RH
    Birth Defects Res A Clin Mol Teratol; 2006 Mar; 76(3):200-4. PubMed ID: 16511884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The risk of defects in the neural tube caused by valproic acid and carbamazepine].
    Gutiérrez-Alvarez AM; Moreno-López CL
    Rev Neurol; 2005 Sep 1-15; 41(5):268-72. PubMed ID: 16138282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Valproic acid increases formation of reactive oxygen species and induces apoptosis in postimplantation embryos: a role for oxidative stress in valproic acid-induced neural tube defects.
    Tung EW; Winn LM
    Mol Pharmacol; 2011 Dec; 80(6):979-87. PubMed ID: 21868484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ribonucleotide reductase subunit R1: a gene conferring sensitivity to valproic acid-induced neural tube defects in mice.
    Craig JC; Bennett GD; Miranda RC; Mackler SA; Finnell RH
    Teratology; 2000 Apr; 61(4):305-13. PubMed ID: 10716750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VPA-related axial skeletal defects and apoptosis: a proposed event cascade.
    Di Renzo F; Broccia ML; Giavini E; Menegola E
    Reprod Toxicol; 2010 Jan; 29(1):106-12. PubMed ID: 19850124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro neuroteratogenicity of valproic acid and 4-en-VPA.
    Gofflot F; Nassogne MC; Etzion T; Van Maele-Fabry G; Evrard P; Picard JJ
    Neurotoxicol Teratol; 1995; 17(4):425-35. PubMed ID: 7565489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The protective effect of polyunsaturated fatty acid intake during pregnancy against embryotoxicity of sodium valproate in mice.
    Li K; Li J; Gu J; Guo X; Gao T; Li D
    Food Funct; 2018 May; 9(5):2634-2643. PubMed ID: 29561026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma vitamin values and antiepileptic therapy: case reports of pregnancy outcomes affected by a neural tube defect.
    Candito M; Naimi M; Boisson C; Rudigoz JC; Gaucherand P; Guéant JL; Luton D; Van Obberghen E
    Birth Defects Res A Clin Mol Teratol; 2007 Jan; 79(1):62-4. PubMed ID: 17120234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.